FIELD: medicine.
SUBSTANCE: method for prediction of a risk of developing renal carcinosarcoma in children and adolescents involves determining major histocompatibility antigens and differing by the fact that serotyping is used to determine the major histocompatibility antigens of HLA class I and II by PCS-SSP, predicting risk groups of developing renal carcinosarcoma in the presence of HLA A26 antigens and DRBI 13 antigens.
EFFECT: simplicity and effectiveness of the method.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING MALIGNANT RETROPERITONEAL TUMOURS IN CHILDREN | 2009 |
|
RU2420239C1 |
| METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF THYROID GLAND MALIGNANT TUMORS IN CHILDREN AND ADOLESCENT | 2005 |
|
RU2300106C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING THYROID GLAND NODULAR NEOPLASMS IN CHILDREN AND ADOLESCENT CASES | 2004 |
|
RU2285923C2 |
| METHOD OF PREDICTING PROCESS GENERALISATION IN CASE OF MALIGNANT BONE TUMOURS | 2010 |
|
RU2427323C1 |
| METHOD OF PROGNOSING GENERALIZATION OF PROCESS IN CHILDREN AND ADOLESCENTS WITH OSTEAL SARCOMA | 2004 |
|
RU2282195C2 |
| METHOD OF PREDICTING GENETIC PREDISPOSITION TO TUBERCULOSIS OF RESPIRATORY ORGANS IN CHILDREN | 2009 |
|
RU2398230C1 |
| METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE | 2019 |
|
RU2814083C2 |
| UNIVERSAL ANTIGEN PRESENTING CELLS AND THEIR USE | 2019 |
|
RU2809113C2 |
| SURVIVIN PEPTIDE VACCINE | 2006 |
|
RU2396088C2 |
| GENETICALLY MODIFIED GAMMA DELTA T CELLS | 2015 |
|
RU2756247C2 |
